Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression is a research paper published in Journal of Clinical Investigation (2023). On theSindex it has a DataRank of 0. It has been cited 67 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
San Diego Center for Precision Immunotherapy
Grant: Neoantigen vaccine development
CCSG
Grant: P30CA23100
NIH HHS
Grant: S10 OD016262
The Sandor and Rebecca Shapery Family
Grant: Shapery Postdoctoral Program
NIH
Grant: U01 DE028227
NIH
Grant: S10 RR027366
NCI NIH HHS
Grant: P30 CA023100
National Institutes of Health
Grant: 1S10OD016262-01
Illumina HiSeq 2500 Sequencing System
National Institutes of Health
Grant: 1S10RR027366-01A1
FACSAria II Cell Sorter
National Institutes of Health
Grant: 5U01DE028227-03
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers
National Institutes of Health
Grant: 3P30CA023100-25S4
Specialized Cancer Center Support Grant
FWCI
7.85
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals